BICARA THERAPEUTICS INC (BCAX:NASDAQ)
$21.13 -0.85 (-3.8672%)
Analysed BICARA THERAPEUTICS INC (BCAX:NASDAQ) News Sources
A Look At Bicara Therapeutics (BCAX) Valuation After Earnings Losses And New Shelf Registration
07-04-2026
yahoo.com
Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
03-04-2026
yahoo.com
Wall Street Analysts Believe Bicara Therapeutics Inc. (BCAX) Could Rally 54.85%: Here's is How to Trade
01-04-2026
yahoo.com
Is CareCloud (CCLD) Stock Outpacing Its Medical Peers This Year?
01-04-2026
yahoo.com
Morning Movers: Sysco dips following deal to acquire Jetro Restaurant Depot
31-03-2026
yahoo.com
Bicara Therapeutics Inc. Common Stock Q4 2025 Earnings Call Summary
31-03-2026
moby.co
Bicara Therapeutics Inc (BCAX) Q4 2025 Earnings Call Highlights: Strong Cash Position and ...
30-03-2026
yahoo.com
Bicara Therapeutics CEO Sold Over 8,000 Company Shares. Is the Stock a Sell or Buy?
30-03-2026
fool.com
Bicara Therapeutics Q4 Earnings Call Highlights
30-03-2026
marketbeat.com
Bicara Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
30-03-2026
yahoo.com
What is the current price of BICARA THERAPEUTICS INC (BCAX:NASDAQ)?
The current price of BICARA THERAPEUTICS INC (BCAX:NASDAQ) is $21.13.
BICARA THERAPEUTICS INC (BCAX:NASDAQ) absolute price change since previous trading day?
The absolute price change of BICARA THERAPEUTICS INC (BCAX:NASDAQ) since the previous trading day is $-0.85.
BICARA THERAPEUTICS INC (BCAX:NASDAQ) percentage price change since previous trading day?
The percentage price change of BICARA THERAPEUTICS INC (BCAX:NASDAQ) since the previous trading day is -3.8672%.
What is the most recent average sentiment score for BICARA THERAPEUTICS INC (BCAX:NASDAQ)?
The most recent average sentiment score for BICARA THERAPEUTICS INC (BCAX:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for BICARA THERAPEUTICS INC (BCAX:NASDAQ)?
The most recent sentiment for BICARA THERAPEUTICS INC (BCAX:NASDAQ) is .
SEC-8K** Filing Available For BICARA THERAPEUTICS INC (BCAX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.